rifapentine (Priftin) for tuberculosis

August 1998

The FDA just approved rifapentine (Priftin) for tuberculosis.It's the first new drug for TB in 25 years.

Think of it as a long-acting rifampin.

They're both in the same class, but Priftin is given less often...just twice a WEEK for two months...then once a week for four months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote